-
The FDA has approved, by priority review, the first drug to help manage patients with phenylketonuria (PKU).
-
Fenofibrate for Diabetic Retinopathy, Does Obesity Cause A Delay in Diagnosis of Prostate Cancer?, and Protecting Bone During Glucocorticoid Treatment
-
-
Research conducted at the Detroit Medical Center found that Cubist Pharmaceuticals' daptomycin for injection (Cubicin®) outperformed vancomycin in resolving the signs and symptoms of complicated skin and skin structure infections.
-
When pharmacists run diabetes management programs for HMO patients, the patients have better health outcomes than patients who are only monitored for long-term blood sugar control. That's the takeaway from a nine-month study that evaluated the effect of such pharmacist-run diabetes management programs.
-
InfoLogix CEO David Guilan says FDA should be involved in encouraging hospitals to adopt barcode and radio frequency identification (RFID) solutions to help prevent medication mix-ups such as occurred with actor Dennis Quaid's children at Cedars-Sinai in Los Angeles.
-
The Pharmacist Services Technical Advisory Coalition (PSTAC) has obtained approval for permanent CPT codes for billing pharmacists' medication therapy management (MTM) services.
-
Further proof of the importance of clinical services to hospital pharmacist care comes in research from the University of Illinois that found that clinical services remain essentially the same no matter how big a hospital is, even when there are differences based on hospital size on a number of workload and productivity measures.
-
The American Society of Health-system Pharmacists (ASHP) says it has intensified its fight against what it sees as a costly and burdensome requirement that hospital outpatient departments report National Drug Code (NDC) numbers.
-
Advances in drug therapy over the last few decades have revolutionized the management of many common disease states.
